INTRODUCTION
Nephrogenic systemic fi brosis (NSF), previously known as nephrogenic fi brosing dermopathy, is a generalised fi brotic disorder occurring in individuals with renal insuffi ciency following exposure to gadolinium-based contrast agents (GdBCA) used to enhance MRI. 1 -5 Clinically, NSF displays many similarities to the clinical manifestations of systemic sclerosis including severe and usually progressive skin induration, progressive and eventually incapacitating joint fl exion contractures and fi brotic involvement of numerous internal organs including lungs, heart, diaphragm and striated muscles. 1 -8 The association of NSF with GdBCA administration has been supported by extensive clinical and epidemiological studies describing the onset of NSF in close temporal relationship with GdBCA use 9 -14 and the presence of Gd in affected tissues from patients with NSF. 15 -18 Furthermore, potent functional effects of GdBCA have recently been described on human peripheral blood monocytes, 19 human skin organ cultures 20 and cultured human dermal fi broblasts. 21 , 22 Following intravenous administration, GdBCA distribute rapidly through the intravascular and extracellular space compartments and Gd chelates are excreted by glomerular fi ltration, with >95% excreted by 1 day, a biological elimination half-life of approximately 1.5 h and no detectable biotransformation, decomposition or serum protein binding. 23 , 24 Because of the renal excretion of these compounds and the demonstrated deposition of Gd in affected tissues of patients with NSF, the accumulation of Gd in tissues in patients with renal insuffi ciency is believed to be a crucial event in the pathogenesis of this condition. Histopathological studies of tissues from affected individuals with NSF suggest that, during the early stages of the disease, the cellular elements involved in the pathogenesis of NSF are activated macrophages 7 and bone marrowderived collagen-producing fi brocytes that infi ltrate the affected tissues. 25 , 26 We examined whether GdBCA could exert a direct effect on human macrophage function and found that Omniscan, the GdBCA studied, causes a remarkable change in the transcriptome of normal human macrophages with a potent stimulation of macrophage chemokine gene expression and production and activation of the nuclear factor κB (NFκB) pathway. We further demonstrated that CCL8/MCP-2 was the most upregulated chemokine in Omniscan-treated macrophages and was also markedly increased in NSF affected skin. The multifunctional cytokines and chemokines released from normal macrophages upon exposure to Omniscan may be able to recruit circulating mononuclear cells and fi brocytes and on an Affymetrix GeneChip Scanner 3000 using GeneChip Operating Software version 3.0. Raw data were normalised using Robust Multichip Average and normalised to control samples with GeneSpring GX v7.3.1 and GX 10.0 software (Agilent). A volcano plot was used to identify differentially expressed genes using parametric testing assuming equal variances and no multiple testing correction. Pathway analysis of differentially expressed genes was performed employing Ingenuity software (Ingenuity Systems, Redwood City, California, USA).
Real-time PCR validation
Expression levels of CCL2 (MCP-1), CCL8 (MCP-2), CXCL10 (IP10) and CXCL11 (ITAC) were assayed by real-time quantitative PCR using SYBR Green chemistry (Applied Biosystems, Foster City, California, USA) following a standard amplifi cation protocol on an ABI Prism 7900 Sequence Detection System (Applied Biosystems). The following primers were employed:
β-Actin: forward 5′-TTGCCGACAGGATGCAGAA-3′, reverse 5′-GCCGATCCACACGGAGTACTT-3′; CCL2 -chemokine, CC motif, ligand 2: forward 5′-ACCAGCAGCAAGTGTCCCAAA-3′, reverse 5′-TTTGCTTGTCCAGGTGGTCCAT-3′; CCL8 -chemokine, CC motif, ligand 8: forward 5′-TCATGCTGAAGCTCACAC CCTT-3′, reverse 5′-AGAATTGCCATTGCACAACTCTT-3′; CXCL10 -chemokine, CXC motif, ligand 10: forward 5′-ACTGCC ATTCTGATTTGCTGCC-3′, reverse 5′-TGATGCAGGTACAGC GTACAGT-3′; CXC11 -chemokine, CXC motif, ligand 11: forward 5′-ACTCCTTCC AAGAAGAGCAGCA-3′, reverse 5′-CCATGCCCTTCACACTCATGTT-3′.
Relative quantifi cation was performed by arbitrarily setting the expression level of the PBS negative control at 100 and by expressing changes in transcript levels of other samples relative to this control sample. Relative differences in each PCR sample were corrected using human β-actin mRNA as an endogenous control. Some experiments were performed employing terminally differentiated macrophages without prior activation (not exposed to PMA) to confi rm that the observed effects were not dependent on PMA activation. Other experiments were performed with macrophages incubated with 500 μM caldiamide to exclude any potential effects that the chelator present in the Omniscan preparations might have caused on the macrophage chemokine gene expression.
Multiplex ELISA
SearchLight proteome array analyses (Pierce Biotechnology, Woburn, Massachusetts, USA) were conducted to measure the levels of CCL8, CXCL10, CCL2 and CXCL11 in culture supernatants from terminally differentiated and activated macrophages following incubation with 50 mM Omniscan for 24 h. 29 Briefl y, culture supernatant samples were diluted 1:2, 1:50 or 1:1000 and then incubated for 1 h on the array plates which had been prespotted with capture antibodies specifi c for each protein. The plates were decanted and washed three times with PBS before addition of a mixture of biotinylated detection antibodies to each well. Following incubation with detection antibodies for 30 min, the plates were washed three times and incubated for 30 min with streptavidin horseradish peroxidase. The plates were again washed and SuperSignal Femto chemiluminescent substrate (Pierce Biotechnology) was added. The plates were immediately imaged using the SearchLight imaging system and data were analysed using ArrayVision software (GE Healthcare, Chalfont St Giles, UK).
activate tissue resident fi broblasts to initiate a fi brotic process as discussed recently. 19 , 22 , 27 Thus, the data presented here indicate that the stimulation of chemokine production and activation of the NFκB pathway in macrophages may play a crucial role in the pathogenesis of NSF.
MATERIALS AND METHODS

Macrophage isolation and differentiation
Normal human peripheral blood buffy coat preparations or leuko-reduction fi lters were obtained from the Thomas Jefferson University Hospital Blood Bank following Institutional Review Board approval. Human peripheral blood mononuclear cells (PBMCs) were isolated from the buffy coat or the leukoreduction fi lters by Ficoll-Hypaque gradient centrifugation (Amersham Pharmacia Biotech, Piscataway, New Jersey, USA) and enriched for monocytes by adherence to plastic culture dishes for 2 h as described. 28 To obtain terminally differentiated macrophages the monocytes were cultured with 60 ng/ml M-CSF (BioVision, Mountain View, California, USA) and 25 ng/ml interleukin 10 (IL-10) (BioVision) for 7 days as described. 28 Macrophages were activated by incubation in the same medium for an additional 24 h with 50 nM phorbol myristate acetate (PMA; Acros Organics, Morris Plains, New Jersey, USA). Activated macrophages (5 × 10 5 cells/ml) were exposed for 24 h to 50 mM Omniscan (GE Healthcare, Lawrence, Massachusetts, USA). No signifi cant effects on cell numbers or increased cytotoxicity were observed as examined by the WST-1 assay (Roche Diagnostics, Indianapolis, Indiana, USA). Certain experiments were performed with differentiated macrophages prepared exactly as described above except that they were not activated by culture with PMA. Macrophage samples cultured with an equal volume of phosphate buffered saline (PBS) served as negative controls. Macrophage culture supernatants were isolated and fi ltered and maintained frozen for subsequent studies. Isolation of total RNA from macrophages was performed as previously described for human monocytes. 19 The Omniscan employed for all the studies was tested and verifi ed by the manufacturer to be free from endotoxin contamination. The endotoxinfree status of Omniscan was further confi rmed utilising the Etoxate Assay (Sigma-Aldrich, St Louis, Missouri, USA) based on Limulus Ameobocyte Lysate (LAL) gel formation, according to the manufacturer's instructions.
Analysis of global gene expression patterns
Global gene expression analysis was performed employing microarrays. For this purpose macrophages from two different donors prepared and activated as described above were incubated for 24 h with either PBS or 50 mM Omniscan. Total RNA was extracted using the RNeasy protocol from Qiagen (Valencia, California, USA). RNA quality was evaluated using the Agilent 2100 Bioanalyzer (Agilent, Palo Alto, California, USA). Total RNA (2 μg) from control and Omniscan-treated samples (two replicates in each group) were used for Affymetrix one cycle target labelling as described by the manufacturer (Affymetrix, Santa Clara, California, USA). Each of four Affymetrix HG U133 plus 2.0 arrays were hybridised for 16 h with biotin-labelled fragmented cRNA (10 μg) in 200 μl hybridisation mixture according to the manufacturer's protocol. Arrays were washed and stained using GeneChip Fluidic Station 450 and hybridisation signals were amplifi ed using antibody amplifi cation with goat IgG (Sigma-Aldrich) and anti-streptavidin biotinylated antibody. Chips were scanned group.bmj.com on December 8, 2010 -Published by ard.bmj.com Downloaded from each incubation with three changes of PBS for 2 min each. Tissue sections or fi xed cells were then counterstained with 4',6-diamidino-2-phenylindole (DAPI) and analysed using a Zeiss LSM 510 META Confocal Laser Scanning Microscope System. Zeiss META confocal microscopy software was used in balancing signal strength. The breakthrough of the DAPI signal into the red and green channels was recorded separately and subtracted from the DAPI blue channel. Each image was scanned eight times to accurately separate signal from noise. Panels were assembled using Adobe Photoshop software without any RGB modifi cation. Quantitative analysis of fl uorescence was performed using ImageJ software (NIH National Institute of Mental Health, Bethesda, Maryland, USA). The integrated density of fl uorescence was calculated in three biopsies and expressed as mean±SD. An unpaired two-tailed t test was used to calculate p values.
NFκB inhibition studies
To demonstrate the participation of NFκB activation in the observed results, macrophages exposed to Omniscan were pretreated by incubation with a cell-permeable NFκB inhibitory peptide. 30 31 The inhibitory peptide was the Iκκ-NBD peptide, which consists of an antennapedia (AP) homeodomain that confers cell permeability, and the T735 to E745 region of Iκκβ which is the NEMO binding domain. This peptide blocks the interaction of NEMO, an IκB complex regulatory protein, with the IκB complex. The control peptide consists of the AP homeodomain sequence alone. The Iκκ-NBD and control peptides (Marligen Biosciences, Ijamsville, Maryland, USA) were dissolved in dimethyl sulphoxide to a concentration of 6.7 mM. Cells were washed with PBS and exposed to 200 μM of either Iκκ-NBD or the control peptide for 2 h. This incubation was followed by addition of either PBS or PBS with 5, 10, 25 or 50 mM Omniscan for 30 min. Cells were washed twice in PBS and lysed in 1 ml iNOS buffer. iNOS protein levels were determined by ELISA as described above.
In other experiments the effects of the cell-permeable NFκB inhibitory peptide on chemokine expression by macrophages incubated either in PBS alone or exposed to 50 mM Omniscan were examined.
Quantitative assessment of iNOS protein levels
Terminally differentiated macrophages were exposed to various concentrations of Omniscan (5-50 mM) for 90 min and the intracellular levels of inducible nitric oxide synthase (iNOS) protein were examined in cell lysates of control and Omniscan-treated cells. The amounts of iNOS present in the macrophage samples were measured with the Quantising human iNOS ELISA kit (R&D Systems, Minneapolis, Minnesota, USA) according to the manufacturer's protocol. The values of iNOS protein present in the samples were expressed as U/ml of cellular lysates by comparison with a standard curve prepared employing recombinant iNOS protein provided by the manufacturer. The calculations were performed within the linear range of the standard curve for all samples.
Indirect immunofl uorescence studies CCL-8 protein was analysed in a sample of normal skin obtained from a healthy individual and in affected skin from three different patients with NSF by immunofl uorescence using a specifi c anti-CCL8 rabbit polyclonal antibody (ABCAM, Cambridge, Massachusetts, USA). Isotype control staining was performed using rabbit IgG (Sigma, St Louis, Missouri, USA). For NFκB localisation studies, macrophages were exposed to Omniscan or saline for 30 min and then fi xed and permeabilised. Anti-p65-NFκB antibodies (Cell Signaling, Danvers, Massachusetts, USA) were used at a 1:100 dilution according to the manufacturer's instructions. Secondary antibodies were affi nity purifi ed sheep FAB′ anti-rabbit IgG, Cy3 conjugated (Sigma, St Louis, Missouri, USA). Paraffi nembedded sections from skin were deparaffi nated with two changes of xylene for 10 min each and then two changes of ethanol for 5 min each. For antigen retrieval the tissue sections were boiled in 10 mM citrate buffer pH 6.0 for 20 min. The sections were then rinsed in PBS for 2 min and incubated with 5% (w/v) normal sheep serum for 20 min at room temperature to block non-specifi c binding sites. The primary antibody incubation step was performed in a dark humidifi ed chamber overnight at 4°C for CCL8. Tissue sections were then incubated with the sheep polyclonal antibodies (1:200). The unbound antibodies were removed from the section following (MCP-2), CXCL10 (IP10), CXCL11 (ITAC) and CXCL12 (SDF1) on the same samples employed for the microarray studies. The results confi rmed and quantifi ed the microarray results, indicating that expression of these genes was increased in normal differentiated and activated human macrophages in response to exposure to 50 mM Omniscan ( fi gure 3A ). Omniscan caused a potent stimulation of the expression of CCL8 (669±108-fold increase), CXCL10 (401±72-fold increase), CCL2 (245±36-fold increase) and CXCL11 (551±48-fold increase) compared with the PBS control levels. To examine whether previous PMA activation of macrophages was required for Omniscan stimulation of chemokine expression, four similar experiments were performed with macrophages without PMA stimulation. The results in fi gure 3B show that PMA activation is not required to elicit the potent stimulation of chemokine expression in macrophages following exposure to Omniscan, and that the pattern of chemokine stimulation was qualitatively similar between samples obtained from Omniscan-exposed macrophages with or without previous PMA activation. Studies with macrophages cultured with caldiamide showed that the chelator alone had no detectable effects on macrophage chemokine gene expression (data not shown). No toxic effects were observed in the macrophages exposed to 50 mM Omniscan, as indicated by the absence of cytotoxicity in WST-1 soluble tetrazolium cytotoxicity assays and the observation of similar levels of housekeeping gene transcripts in quantitative PCR arrays (data not shown).
RESULTS
Global gene expression of control and Omniscan-exposed normal human macrophages
Comparison between the average gene expression signals for the replicates between Omniscan-exposed and control macrophages revealed 551 differentially expressed genes (more than twofold) ( fi gure 1A ). Table 1 in the online supplement shows a list of all the differentially expressed genes. In many instances the differential expression was of a large magnitude (up to 19-fold). A volcano plot analysis of the differentially expressed transcripts ( fi gure 1B ) revealed that 240 of them were upregulated and 311 were downregulated by more than twofold with high statistical signifi cance (p<0.05). Of these 240 upregulated transcripts, 31 had a signal intensity >100 and corresponded to genes with a known function on the NCBI database. We defi ned the transcripts for these 31 genes as representing the 'macrophage Gd signature'. Five of these 31 transcripts corresponded to chemokines and three to interferon-inducible genes. The complete list is shown in fi gure 2 . CEL fi les for all the samples analysed will be made publicly available through the NCBI following publication.
Real-time PCR validation
To validate the microarray results and to further characterise the chemokine expression levels in macrophages following incubation with Omniscan, we performed real-time quantitative PCR analysis of mRNA levels for CCL2 (MCP-1), CCL8
Figure 2
The macrophage Gd signature genes. Comparisons were performed between transcript expression levels of cells exposed to 50 mM Omniscan and phosphate buffered saline (PBS) control macrophages on the Affymetrix U133 2.0 Plus microarray, which yielded a group of 31 transcripts excluding orphan genes and transcript redundancies. Genes were considered signifi cant if the p value of the differences was <0.05, the signal intensity of their expression was >100 and the fold change average signal intensity was >2. Highlighted in red are transcripts for chemokines of the interferon pathway.
skin from three patients with NSF. Immunofl uorescence studies followed by quantitative confocal microscopy analysis showed that, in contrast to normal skin from a healthy individual, affected skin from three patients with NSF displayed a marked increase in the level of fl uorescence for MCP-2/CCL8 ( fi gure 4A ); the increase was apparent in both the upper and lower dermis and was consistent in the three biopsies examined (p<0.0001, fi gure 4B ).
Pathway analysis of microarray data revealed strong NFκB activation
Pathway analysis of all the signifi cantly (more than twofold, p<0.05) differentially increased genes in the transcriptome of Omniscan-treated macrophages indicated a strong activation of the NFκB pathway ( fi gure 5 ). All the macrophage chemokines found to be upregulated in response to Omniscan exposure are downstream targets of NFκB activation. Given the strong NFκB pathway activation suggested by these results, all reagents were
Multiplex ELISA of tissue culture supernatants from microarray studies
Culture media isolated from normal human differentiated and activated macrophages exposed to 50 mM Omniscan were analysed by the Searchlight Proteome Array Assay. Consistent with the mRNA expression results, we observed a marked increase in the production and secretion of various chemokines compared with the levels from control macrophages incubated with PBS. The concentrations of selected cytokines found in the culture medium of Omniscan-stimulated macrophages are shown in fi gure 3C .
MCP-2/CCL8 expression is increased in NSF skin
To further validate the in vitro results and to determine whether the observed increase in chemokine production was pertinent to the pathogenesis of NSF, we examined the expression of MCP-2/CCL8, the most upregulated chemokine in the microarray, in paraffi n-embedded skin biopsies from affected as early as 5 min after macrophage incubation with 50 mM Omniscan, a striking NFκB nuclear localisation was observed, indicating a strong activation of this pathway. The observed nuclear localisation was completely abrogated by pretreatment of the macrophages with a cell-permeable NFκB inhibitory (Iκκ-NBD) peptide ( fi gure 6B ) but was not changed by pretreatment with the AP control peptide.
Omniscan stimulated iNOS protein levels in differentiated normal human macrophages through NFκB activation
To further confi rm the activation of NFκB, we measured the levels of iNOS protein in cell lysates from differentiated macrophages without prior PMA activation following incubation with various concentrations (5-50 mM) of Omniscan ( fi gure 6C,D ). The basal level of iNOS in control macrophages was ~0.015 U/ml of cell lysate. Following 30 min incubation with all concentrations of Omniscan there was a potent increase in iNOS levels (10-to 25-fold) with a dose response that reached a plateau at 25 mM ( fi gure 6C ). To examine the role of NFκB in the stimulation of iNOS protein levels, the effects of NFκB inhibition by pretreatment with the inhibitory Iκκ-NBD peptide were analysed. The results are shown in fi gure 6D . Exposure to Omniscan caused a concentration-dependent increase in iNOS protein levels, with 5 mM inducing a 36-fold increase and 50 mM a 157-fold increase. This stimulation was essentially completely abolished by incubation with the Iκκ-NBD inhibitory peptide but was not affected by the AP control peptide.
Omniscan stimulation of chemokine gene expression is dependent on NFκB activation
To determine whether NFκB activation was required for Omniscan stimulation of macrophage chemokine production, terminally differentiated macrophages without prior PMA stimulation were preincubated with the NFκB cell-permeable inhibitory peptide and then exposed to Omniscan (50 mM) for 24 h. Quantitative assessment of transcript levels showed that pretreatment with the Iκκ-NBD peptide completely abrogated the Omniscan-induced upregulation of CCL8, CXCL10 and CXCL11 and reduced by ~85% the upregulation of CCL2 ( fi gure 6E ). These results demonstrated that exposure to Omniscan elicits potent chemokine gene expression stimulation in macrophages that is dependent on NFκB activation but independent of prior PMA activation.
DISCUSSION
The activation of tissue macrophages is known to play a critical role during the wound healing process, orchestrating both the onset and the resolution of the fi brotic phase. 32 -34 The study of the pathological processes occurring in systemic fi brotic diseases such as systemic sclerosis has revealed the presence of macrophages in the affected tissues, particularly during the early stages of tissue involvement. 35 36 Macrophage infi ltration has also been described in the affected skin of patients with NSF, 7 and electron scanning microscopy and energy dispersive x-ray spectroscopy revealed intracellular Gd deposits in macrophages in affected NSF skin. 15 These elegant studies, however, did not provide any functional evidence that the Gd deposits caused functional effects or alterations in the macrophage cell populations.
The studies described here examined directly the role of an interaction between GdBCA and macrophages by exposing normal differentiated human macrophages to the GdBCA Omniscan. confi rmed to be endotoxin-free using a LAL gel formation assay (data not shown).
Omniscan induced NFκB nuclear localisation in terminally differentiated macrophages
To confi rm functionally the NFκB activation suggested by the pathway analysis, we examined the effects of Omniscan on NFκB nuclear localisation in normal macrophages. As shown in fi gure 6A , in macrophages incubated under control conditions the localisation of NFκB is mostly cytoplasmic. In contrast, 
used here are substantially higher than those found in the circulation of individuals with normal renal function following their administration for imaging studies, the actual concentrations of these compounds in the tissues of patients with renal insuffi ciency are very likely to be much greater than those calculated from pharmacokinetic studies. For example, in a study of patients with chronic renal failure on haemodialysis receiving 0.1 mmol/kg administrations of Gd-DTPA (Magnevist) before haemodialysis, serum concentrations as high as 50 μmol Gd/ ml were observed. 37 Furthermore, recent studies have demonstrated the selective accumulation of Gd in macrophages and fi brocytes in affected skin from patients with NSF, 15 suggesting that the distribution of GdBCA in affected tissues is not homogeneous and that GdBCA can be concentrated in tissue macrophages resulting in cellular exposure to much higher concentrations of these compounds.
The reasons why only certain individuals with renal insuffi ciency exposed to GdBCA develop NSF are not known. However, it is very likely that there is great variability in the cellular response to GdBCA among individuals. Indeed, in our previous study 19 we observed that PBMCs from different donors display different patterns of activation following incubation with similar concentrations of the same contrast agent. We have suggested that this variation must be related to a permissive genetic background that may infl uence the threshold and the pattern of cellular activation.
This compound was chosen because it is the most common GdBCA to which patients who subsequently developed NSF had been exposed. Another reason for our focus on this GdBCA was that, in a previous study, we performed a detailed comparison of several GdBCA on PBMC function 19 and found that, despite numerous quantitative and qualitative differences in the levels of cytokine/chemokine stimulation between the different GdBCA, the most potent effects were observed with Omniscan. However, we also performed a microarray analysis on terminally differentiated normal human macrophages incubated with another GdBCA, Gd-DTPA. The effects of Omniscan were substantially stronger in inducing macrophage activation than those induced by Gd-DTPA.
The microarray analysis of transcriptome changes occurring in normal human macrophages as a result of exposure to Omniscan demonstrated a remarkable change in their transcriptome that results in the differential expression of 551 genes, as depicted in fi gure 1 and listed in table 1 in the online supplement. Although the Gd-DTPA data are not described, a table of the differentially expressed genes in human macrophages following Gd-DTPA stimulation is included in table 2 in the online supplement. A volcano plot analysis of the most differentially expressed genes following macrophage exposure to Omniscan revealed the increased expression of genes encoding numerous chemokines known to be potent chemoattractants for bone marrow-derived cells. Although the concentrations of GdBCA chemokines in response to Omniscan exposure, we analysed the cluster of upregulated genes by pathway analysis. This analysis indicated that most of the chemokines found to be increased following GdBCA exposure are known to be induced as a result of the activation of NFκB ( fi gure 5 ). To determine whether the observed macrophage activation was caused by stimulation of the NFκB pathway we analysed the nuclear localisation of NFκB and the levels of iNOS in differentiated macrophages following incubation with Omniscan ( fi gure 6 ). We observed that 5 min incubation was suffi cient to induce essentially complete nuclear localisation of NFκB, indicating a strong activation of this pathway. Furthermore, Omniscan induced a potent dose-dependent stimulation of iNOS protein levels and chemokine production in the same cells. Inhibition of intracellular NFκB with a cellpermeable inhibitory peptide showed that NFκB activation was
The results shown in fi gure 3A confi rmed and quantifi ed the results of the microarray experiments indicating that the expression of numerous chemokine genes was increased in normal differentiated human macrophages. Furthermore, the results shown in fi gure 3B show that these effects were independent of PMA macrophage activation. Assessment of chemokine protein levels in media of GdBCA-exposed macrophages confi rmed the increase in production of CCL8, CCL2, CXCL9 and CXCL11 ( fi gure 3C ). Most importantly, immunofl uorescence studies with confocal microscopy of affected skin from three patients with NSF indicated that CCL8, the most upregulated chemokine, was markedly increased in comparison with normal skin ( fi gure 4A,B ).
To gain an insight into the mechanisms responsible for the remarkable increase in the macrophage production of these group.bmj.com on December 8, 2010 -Published by ard.bmj.com Downloaded from necessary for the observed increase in iNOS levels and stimulation of chemokine expression in normal macrophages following Omniscan exposure.
The data reported here show that GdBCA can induce a potent activation of normal macrophages and suggest that a similar mechanism may be responsible for the macrophage activation observed in NSF-affected tissues. Although these observations strongly implicate macrophage participation in this unique fi brotic process, the role of any cell type in NSF is presumptive since no single cell type has been defi nitively demonstrated to be responsible for the spectrum of histological and pathological changes observed in this condition. Indeed, we consider it highly unlikely that a single cell type is responsible for mediating all the effects of GdBCA in the induction of NSF. However, the contention that macrophages may play an important role in this process is supported by strong experimental evidence indicating that macrophages play a role in wound healing 32 -34 and in the pathogenesis of systemic sclerosis. 35 36 The involvement of monocytes and macrophages suggested here does not preclude effects of GdBCA on other cells present in lesions such as fi brocytes and fi broblasts. Furthermore, it is widely accepted that there is an increased number of fi brocytes (CD34) in the skin of patients with NSF. These cells are of bone marrow origin and home to the skin following a specifi c chemokine gradient. In this sense, a specifi c activation of macrophages causing increased production and a gradient of chemokines is very likely to occur and to be crucial in the process.
Although the studies reported here were conducted in vitro, the kinetics of response we observed, including a potent NFκB nuclear localisation as early as 5 min following exposure to Omniscan, suggest that normal human macrophages are capable of reacting directly to the Gd-chelate complex. The kinetics of response and the activation of NFκB are similar to those observed following lipopolysaccharide stimulation, suggesting a possible involvement of Toll-like receptor (TLR) signalling in this process. Additional studies are in progress to further examine the role of TLR signalling in GdBCA-induced macrophage activation in the initiation and progression of tissue fi brosis.
The results described here show conclusively that Omniscan is able to activate macrophages and induce their production of numerous chemokines that are known to be involved in the pathogenesis of tissue fi brosis. Indeed, we found potent stimulation of chemokines such as CXCL10 which have been shown to be raised in the serum of some patients with systemic sclerosis 38 and to participate in wound healing. 39 Furthermore, we clearly demonstrate that the activation responsible for their production is NFκB-mediated. Thus, the principal conclusion of the studies described here is that the GdBCA Omniscan, when in contact with terminally differentiated macrophages, is able to activate them towards a profi brotic phenotype and therefore this could trigger a sequence of events that is responsible for the development of the clinical picture of NSF in a genetically permissive background. Most importantly, this paradigm could be used to investigate the very early events in the pathogenesis of idiopathic tissue fi brotic disorders such as systemic sclerosis or idiopathic pulmonary fi brosis, conditions in which the triggering events are not known, thus precluding a detailed analysis of the early steps in their pathogenesis. In this regard, environmentallyinduced diseases such as GdBCA-induced NSF may offer a very valuable model to study the cascade of early events that lead to a given pathological fi brotic disease phenotype.
